Preclinical evaluation showed SQ3370 alters immune microenvironment in MC38 tumors, suggesting clinical promise.
Supplementary Fig S6. SQ3370 induces changes in the immune microenvironment of MC38 tumors.
No takes yet. Share an insight, caveat, or question.
Srinivasan et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: